Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Monod Bio licenses AI-designed protein technologies to SignalChem Biotech for custom discovery assays

  • Posted on August 27, 2026
  • By Google News
  • 0 Views
  • 1 min read
In brief

Generating AI summary…

Monod Bio licenses AI-designed protein technologies to SignalChem Biotech for custom discovery assays
Monod Bio licenses AI-designed protein technologies to SignalChem Biotech for custom discovery assays

Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc., today announced a non-exclusive licensing agreement covering Monod Bio’s proprietary LuxSit de novo luciferase technology and NovoBodies.
continue reading...

Author
Google News

You May Also Like